Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Insights and Updates: New Data on Next-Generation Retinal Treatments
Durga Borkar, MD, MMCi
Veeral Sheth, MD, MBA, FASRS, FACS
Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma Activity
Joshua Richter, MD
Sagar Lonial, MD, FACP
Noopur Raje, MD
Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
Safety First: Navigating CELMoD-Associated Toxicities
Real-World Ready: Practical Tips for Community Oncologists
Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Maria Fleseriu, MD, FACE
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
John M. Kirkwood, MD
Sapna Patel, MD
Data Dive: Clinical Evidence Behind CELMoDs
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
Why CELMoDs Matter in Myeloma
Next-Generation Innovations: The Future of CELMoDs in Myeloma
Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach
Heather Wakelee, MD, FASCO
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
Kevin Kalinsky MD, MS
Komal Jhaveri, MD, FACP
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management
Robert J. Motzer, MD
Elizabeth R. Plimack, MD, MS, FASCO
Advancing Myasthenia Gravis (MG) Treatment Through Guideline Updates and Emerging Therapies
October 30, 2025
02:45 PM - 03:45 PM ET
San Francisco, California
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD
Lea Azour, MD
Ashwin Basavaraj, MD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.